Ad35-GRIN/ENV

BIOLOGICAL2 trials

Sponsors

International AIDS Vaccine Initiative

Conditions

HIVHIV Infections

Phase 1

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

CompletedNCT00851383

International AIDS Vaccine InitiativeHIV, HIV Infections

Start: 2009-03-31End: 2011-08-31Updated: 2012-04-25

Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers

CompletedNCT01496989

International AIDS Vaccine InitiativeHIV Infections

Start: 2011-12-31Target: 75Updated: 2013-09-02

Related Papers

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial

PLoS ONE2020-05-2919 citations

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

PLoS ONE2015-08-0743 citations

A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.

2012-08-0369 citations